Michael George, MD
Pediatric Orthopaedic Surgery · Houston, TXNPI 1235110222
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $8,925 of the $13,370 with a category attached, or 66.8%. 23 manufacturers reported payments, led by Smith+Nephew at 52.0% of the total. Reporting peaked in 2021 at $7,709 and has fallen 81.9% since, to $1,392 in 2025.
Across 118 payments — averaging $113.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$7K
- Integra Lifesciences Corporation$2K
- Medacta USA, Inc.$2K
- Stryker$896
- Pacira Therapeutics, Inc.$456
- Ferring Pharmaceuticals Inc.$291
- plus $605 from 17 others
What the payments were for
- Consulting fees$8,92567%
- Speaking & faculty fees$2502%
- Travel & lodging$9327%
- Food & beverage$3,26324%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 12 | $6,956 |
| Integra Lifesciences Corporation | 6 | $2,115 |
| Medacta USA, Inc. | 6 | $2,050 |
| Stryker(2 entities) | 20 | $896 |
| Pacira Therapeutics, Inc. | 31 | $456 |
| Ferring Pharmaceuticals Inc. | 15 | $291 |
| Catalyst Orthoscience | 2 | $130 |
| Johnson & Johnson | 7 | $108 |
| Zimmer Biomet | 1 | $45 |
| Globus Medical | 1 | $33 |
| Davol Inc. | 2 | $33 |
| Painteq LLC | 1 | $31 |
| Abbott | 2 | $28 |
| Innovation Technologies Inc | 1 | $28 |
| Amgen | 2 | $26 |
| Biodelivery Sciences International, Inc. | 2 | $26 |
| FX Shoulder Solutions, Inc | 1 | $23 |
| Vericel Corporation | 1 | $19 |
| Pacira Pharmaceuticals Incorporated | 1 | $19 |
| Boston Scientific | 1 | $18 |
| Anika Therapeutics, Inc. | 1 | $17 |
| Baudax Bio Inc. | 1 | $12 |
| Arthrosurface Incorporated | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TITAN-SHOULDER$4,800
- FREEDOM WRIST$2,025
- External Fixation System$1,775
- REVERSE SHOULDER$1,500
- MECTA$1,374
- Mecta-C Cervical Cages$600
- SALTO TALARIS TOTAL ANKLE PROSTHESIS$283
- CADENCE ANKLE REPLACEMENT SYSTEM$283
- HALLU-LOCK$283
- PANTA NAIL$283
- TOTAL FOOT SYSTEM$283
- TRIATHLON$282
- PYRO MCP$275
- TSSM - TOTAL SHOULDER SYSTEM METAL$275
- Cadence$250
- LUNATE$250
- MCP$250
- PIP$250
How this compares
$13,370 in reported general payments places this provider in the 80th percentile of 82 pediatric orthopaedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 140 | $25,693 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 533 | $5,715 |
| Celecoxib | 380 | $4,426 |
| Meloxicam | 318 | $929 |
| Ondansetron Hcl | 259 | $838 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 98 | $786 |
| Tramadol Hcl | 199 | $562 |
| Gabapentin | 165 | $532 |
| Nabumetone | 16 | $299 |
| Naproxen | 69 | $237 |
| Cyclobenzaprine Hcl | 13 | $74 |
| Ibuprofen | 14 | $73 |
| Tizanidine Hcl | 14 | $63 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $58 |
| Amoxicillin | 59 | $41 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $108 | $25,693140 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 82 pediatric orthopaedic surgery providers in Texas.
Other pediatric orthopaedic surgery in Houston
- Gary BrockHouston$221K
- Jaclyn HillHouston$70K
- Scott RosenfeldHouston$31K
- Margaret BaldwinHouston$23K
- Antony AntonyHouston$18K
- Jessica McGraw-HeinrichHouston$11K
- Pablo CastanedaHouston$10K
- Shiraz YounasHouston$10K
- Aharon GladsteinHouston$8K
- Timothy BordenHouston$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.